- Home
- SYBX vs REE Comparison
SYBX vs REE Comparison
Compare SYBX & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- REE
- Stock Information
- Founded
- SYBX N/A
- REE 2011
- Country
- SYBX United States
- REE Israel
- Employees
- SYBX N/A
- REE N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- REE Auto Manufacturing
- Sector
- SYBX Health Care
- REE Consumer Discretionary
- Exchange
- SYBX Nasdaq
- REE Nasdaq
- Market Cap
- SYBX 16.4M
- REE 18.5M
- IPO Year
- SYBX N/A
- REE N/A
- Fundamental
- Price
- SYBX $1.71
- REE $0.74
- Analyst Decision
- SYBX
- REE Strong Buy
- Analyst Count
- SYBX 0
- REE 2
- Target Price
- SYBX N/A
- REE $11.75
- AVG Volume (30 Days)
- SYBX 21.1K
- REE 63.0K
- Earning Date
- SYBX 11-11-2025
- REE 09-16-2025
- Dividend Yield
- SYBX N/A
- REE N/A
- EPS Growth
- SYBX N/A
- REE N/A
- EPS
- SYBX N/A
- REE N/A
- Revenue
- SYBX N/A
- REE $183,000.00
- Revenue This Year
- SYBX N/A
- REE $6,661.20
- Revenue Next Year
- SYBX N/A
- REE $2,240.01
- P/E Ratio
- SYBX N/A
- REE N/A
- Revenue Growth
- SYBX N/A
- REE N/A
- 52 Week Low
- SYBX $0.90
- REE $0.53
- 52 Week High
- SYBX $1.96
- REE $11.72
- Technical
- Relative Strength Index (RSI)
- SYBX 69.98
- REE 58.54
- Support Level
- SYBX $1.45
- REE $0.68
- Resistance Level
- SYBX $1.77
- REE $0.75
- Average True Range (ATR)
- SYBX 0.07
- REE 0.04
- MACD
- SYBX 0.03
- REE 0.01
- Stochastic Oscillator
- SYBX 83.33
- REE 77.27
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.